Archives
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
Lanabecestat (AZD3293): Blood-Brain Barrier BACE1 Inhibit...
2026-01-31
Lanabecestat (AZD3293) is a potent, blood-brain barrier-crossing BACE1 inhibitor central to Alzheimer’s disease research. This article details its mechanism, benchmarks its synaptic safety, and clarifies key applications and boundaries for amyloidogenic pathway modulation.
-
Zosuquidar (LY335979) 3HCl: High-Specificity P-gp Inhibit...
2026-01-30
Zosuquidar (LY335979) 3HCl is a potent, selective P-glycoprotein modulator that enables effective reversal of multidrug resistance (MDR) in cancer research. This compound restores drug sensitivity in P-gp overexpressing cells and enhances in vivo efficacy of chemotherapeutics, with proven benchmarks in leukemia and solid tumor models. As supplied by APExBIO, Zosuquidar (LY335979) 3HCl is a key tool for dissecting and overcoming MDR in preclinical workflows.
-
Calpain Inhibitor I (ALLN): Advanced Insights for Disease...
2026-01-30
Explore the multifaceted role of Calpain Inhibitor I (ALLN) as a potent calpain and cathepsin inhibitor in apoptosis assays, inflammation research, and predictive disease modeling. This in-depth analysis reveals novel applications and experimental strategies, setting it apart from conventional content.
-
Solving Real Lab Challenges with One-step TUNEL Cy5 Apopt...
2026-01-29
This scenario-driven article guides biomedical researchers and laboratory professionals through common challenges in apoptosis quantification and workflow design. Drawing on the robust formulation and broad compatibility of the One-step TUNEL Cy5 Apoptosis Detection Kit (SKU K1135), we present evidence-based solutions for reproducible, sensitive detection of programmed cell death across tissue and cell models. Actionable guidance is anchored in validated protocols, peer-reviewed literature, and hands-on laboratory experience.
-
Fluo-4 AM: Optimizing Calcium Imaging for Advanced Cell S...
2026-01-29
Unlock the full potential of intracellular calcium concentration measurement with Fluo-4 AM, the gold-standard fluorescent calcium indicator from APExBIO. Discover actionable workflow enhancements, expert troubleshooting advice, and real-world use-cases that are transforming calcium signaling assays and bioelectronic research.
-
Z-WEHD-FMK: Unveiling New Horizons in Caspase-5 Inhibitio...
2026-01-28
Explore the advanced scientific mechanisms and applications of Z-WEHD-FMK, a potent irreversible caspase-5 inhibitor, in inflammation and infectious disease research. This article offers unique insights into caspase signaling modulation and pyroptosis inhibition, setting it apart from existing resources.
-
Adefovir (SKU C6629): Data-Driven Solutions for Reliable ...
2026-01-28
This evidence-based article guides biomedical researchers and lab technicians through practical, scenario-driven challenges in hepatitis B virus (HBV) research, highlighting how Adefovir (SKU C6629) from APExBIO offers reproducible, high-quality results. Drawing on recent pharmacokinetic literature and peer benchmarks, the guide details best practices for experimental design, compatibility, optimization, and product selection, ensuring that scientists achieve robust, actionable data in cell-based antiviral assays.
-
Cell Counting Kit-8 (CCK-8) Plus: Scenario-Driven Best Pr...
2026-01-27
This article provides a scenario-based, data-backed exploration of laboratory challenges in cell viability and proliferation assays, highlighting how Cell Counting Kit-8 (CCK-8) Plus (SKU K2268) addresses issues of sensitivity, reproducibility, and workflow efficiency. Readers will gain actionable insights into assay optimization, product selection, and data interpretation, with direct links to validated protocols and scientific references.
-
BODIPY 581/591 C11: Ratiometric Lipid Peroxidation Detect...
2026-01-27
BODIPY 581/591 C11 empowers researchers with precise, ratiometric detection of lipid peroxidation and oxidative stress across live-cell and membrane models. Its robust performance, specificity to oxygen radicals, and compatibility with diverse workflows make it a gold standard for antioxidant capacity evaluation and ferroptosis research.
-
Liproxstatin-1: Potent Ferroptosis Inhibitor for Lipid Pe...
2026-01-26
Liproxstatin-1 is a potent ferroptosis inhibitor (IC50 22 nM) enabling precise modulation of lipid peroxidation in GPX4-deficient and iron-dependent cell death models. This article details its mechanism, benchmarks, and best practices for integration in ferroptosis research.
-
DIDS: Advanced Mechanisms and Emerging Roles in Cancer an...
2026-01-26
Explore the multifaceted actions of DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid), a premier anion transport inhibitor, with a deep dive into its unique molecular mechanisms and translational applications in cancer research and neurodegenerative disease models. This article offers a distinct, evidence-driven perspective on how DIDS is redefining chloride channel modulation and therapeutic innovation.
-
Sulfaphenazole: Strategic CYP2C9 Inhibition for Transform...
2026-01-25
This thought-leadership article examines Sulfaphenazole as a highly selective competitive CYP2C9 inhibitor, illuminating its mechanistic impact on drug metabolism, vascular endothelial function, and ischemia–reperfusion injury. Blending recent in vivo evidence and translational strategy, we delineate how APExBIO's Sulfaphenazole (C4131) empowers researchers to unravel pharmacogenetic complexities, modulate oxidative stress, and set new benchmarks for adverse drug reaction modeling beyond conventional product descriptions.
-
MDL 28170: Selective Calpain and Cathepsin B Inhibition f...
2026-01-24
MDL 28170 is a selective, cell-permeable calpain and cathepsin B inhibitor widely used in apoptosis and neuroprotection research. Its specificity, blood-brain barrier permeability, and nanomolar potency make it a benchmark tool for dissecting calpain-mediated proteolysis in ischemia-reperfusion and neurodegenerative models.
-
Q-VD-OPh: Pan-Caspase Inhibition as a Precision Tool for ...
2026-01-23
Explore the multifaceted roles of Q-VD-OPh, a potent pan-caspase inhibitor, in apoptosis research and mitochondrial quality control. This article uniquely connects irreversible caspase inhibition to emerging insights on mitophagy and disease modeling, providing advanced perspectives for experimental design.
-
U 46619 (SKU B6890): Practical Solutions for Reliable Pla...
2026-01-23
This article delivers scenario-based guidance for biomedical researchers and lab technicians seeking reproducible cell viability, platelet aggregation, and renal ischemia-reperfusion assays using U 46619 (SKU B6890). Drawing on quantitative data, peer-reviewed literature, and direct product comparisons, it demonstrates how U 46619 provides reliable, validated results and practical workflow advantages for demanding laboratory settings.